Jazz Pharmaceuticals (JAZZ) Return on Equity (2011 - 2026)

Jazz Pharmaceuticals has reported Return on Equity for 16 years, with the latest figure at 0.0% in Q1 2026.

• For the quarter ending Q1 2026, Return on Equity changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Equity for Q1 2026 stood at 0.0%, up from 0.0% in the prior quarter.
• The five-year high for Return on Equity was 0.0% in Q4 2024, with the low at 0.0% in Q1 2022.
• Average Return on Equity over 5 years is 0.0%, with a median of 0.0% recorded in 2022.
• Peak annual rise in Return on Equity reached 0 bps in 2022, while the deepest fall reached 0 bps in 2022.
• Tracing JAZZ's Return on Equity over 5 years: stood at 0.0% in 2022, then surged by 257 bps to 0.0% in 2023, then rose by 18 bps to 0.0% in 2024, then plunged by 163 bps to 0.0% in 2025, then soared by 108 bps to 0.0% in 2026.
• The last three Return on Equity figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.

Peer Comparison